Company Overview
Company Name
ABK Biomedical
Address
155 Chain Lake Drive, Halifax, NS, Canada
Website
abkbiomedical.comPhone
+1 902 442 4009Approx. Annual Revenue
$7.2M
Employees
40
Established
2012
About ABK Biomedical
ABK Biomedical is a company based in Halifax, Nova Scotia, Canada, that focuses on developing novel Y90 radioembolization treatment options for patients with hypervascular liver tumors. The company's lead product, Eye90 Microspheres, has been granted breakthrough device designation by the U.S. Food and Drug Administration, and the company is conducting a multi-center pivotal study of the device.
Business Profile
Read from the ABK Biomedical website on Oct 13, 2026. Hover an item to see the exact wording it came from.
Licenses, certifications & awards
- ISO CertifiedIndustry certified
About the website
- Website quality (AI-assessed)
- 8/10 · Current news and press releases; Detailed product and trial information
- Footer copyright year
- 2022
Frequently Asked Questions about ABK Biomedical
Advertising Pixels
- Google Ad Pixel
